1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2022 | |
|---|---|---|
| Revenue | 1.87M | 26.53% |
| Gross profit | -787.12K | 63.28% |
| Net profit | -2.34M | 45.43% |
| EBITDA | -1.25M | 62.64% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €176.95K |
Number of shares | 205.02M |
52-week high/low | €0.0211 - €0.000863 |
| Dividends | No |
Beta | -0.36 |
P/E ratio | -1.07 |
PEG ratio | 0.04 |
P/B ratio | 0.47 |
P/S ratio | 0.98 |
Company profile
THC Biomed Intl Ltd. produziert und vertreibt medizinisches und Freizeit-Cannabis in Kanada. Es bietet Cannabis-Getränkeshots, -Gummis und -Kekse unter dem Markennamen THC KISS sowie reine Cannabis-Sticks an. Das Unternehmen wurde im Jahr 2012 gegründet und hat seinen Hauptsitz in Kelowna, Kanada.
| Name | THC BIOMED INTL |
| CEO | John Miller |
| Headquarters | Kelowna,
bc Canada |
| Website | |
| IPO | 08/09/1996 |
| Employees | 35 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | THCBF |
Cnq | THC.CN |
Frankfurt | TFHD.F |
München | TFHD.MU |
Discover assets
Shareholders of THC BIOMED INTL also invest in the following assets
